Protocol No.UW22078
ALTUS 2021-01
Principal InvestigatorSaid, Adnan
PhaseN/A (Cancer Control) (Cancer Prevention)
Age GroupAdult
ClinicalTrials.GovNCT05064553 (Click to jump to clinicaltrials.gov)
Management Group(s) CTI - Regulatory; Gastroenterology/Hepatology Research; Oncology Outside Research Groups (ORG)

Title
ALTUS: Performance of a Multi-Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Description
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Objective
The primary objective is to assess overall sensitivity and specificity of Oncoguard™ Liver for hepatocellular cancer (HCC) detection in a surveillance population.

Treatment The study will include participants aged 18 years and older who are at increased risk for HCC, including individuals with liver cirrhosis or non-cirrhotic individuals with chronic hepatitis B infection.

Key Eligibility For full study eligibility, see this study's ClinicalTrials.gov record.

Applicable Disease Sites
Liver

Participating Institutions
UW - Madison; UW Health Digestive Health Center